Search
SOLACI Congress
HomeStructural heart diseaseValvular Aortic valve

Valvular Aortic valve

View Category

Structural heart disease

Meta-analysis on Cerebral Embolic Protection in TAVR

Cerebral embolic protection is a strategy to prevent embolization of thrombotic or calcific debris during transcatheter aortic...
solaci -
Learn More
Structural heart disease

Evolut R: Clinical Results Might Be Better than Those for First-Generation CoreValve

Two recent articles featured in  JACC Cardiovascular Interventions  showed that short term (at 30 days) outcomes of patients...
solaci -
Learn More
Structural heart disease

Post-Dilation of Self-Expanding Valves: Frequency, Usefulness, and Risks

This study explores the impact of balloon post-dilation on studies conducted in the United States assessing the...
solaci -
Learn More
Structural heart disease

Asymptomatic Severe Aortic Stenosis in the Elderly: When to Intervene

This work studies the natural history of aortic stenosis and the optimal timing to intervene elderly patients...
solaci -
Learn More
Structural heart disease

TAVR: Reasons to Consider Mitral Annular Calcification

Courtesy of Dr. Carlos Fava. Aortic valve calcification and mitral annular calcification have the same etiology and are frequently...
solaci -
Learn More
Structural heart disease

4 Readmission Predictors after Successful TAVR

Readmissions are frequent after cardiovascular procedures and they significantly increase healthcare costs. Data on readmission need within...
solaci -
Learn More
Mitral valve

Transcatheter Mitral Valve Replacement for Severe Mitral Regurgitation: A Global Study

Symptomatic mitral regurgitation is associated with high morbidity and mortality that can be alleviated partly by surgical...
solaci -
Learn More
Structural heart disease

Transcatheter Valve Thrombosis: Predictors, Incidence, and Events

This study sought to clarify the incidence and predictors of hypoattenuated leaflet thickening (assumed as leaflet thrombosis)...
solaci -
Learn More

SOLACI is the reference organization for Latin American cardiovascular interventionism.

Last News

Dynamic Coronary Roadmap: does it really help reduce contrast use?

Dr. Juan Manuel Pérez - 0
Contrast-induced nephropathy remains a relevant complication of percutaneous coronary interventions (PCI), particularly in patients with multiple comorbidities and complex coronary anatomies. Dynamic Coronary Roadmap...

Endoleaks after endovascular repair of complex aortic aneurysms: always reintervene or monitor with CTA?

Dr. Juan Manuel Pérez - 0
Endovascular repair of thoracoabdominal aneurysms requiring sealing above the renal arteries, with preservation of visceral vessels using fenestrated and/or branched devices (F/B-EVAR), has become...

Is it safe to use negative chronotropic drugs early after TAVI?

Dr. Juan Manuel Pérez - 0
TAVI is associated with a relevant incidence of conduction system disturbances and the development of atrioventricular block that may require permanent pacemaker implantation. Many...

Institutional News

SOLACI Wishes You Happy Holidays

solaci - 0
From the heart, Happy Holidays! The Latin American Society of Interventional Cardiology wishes all its members and the medical community across the continent a very Merry Christmas...

Condolences on the passing of Cristiam Arancibia

solaci - 0
The Latin American Society of Interventional Cardiology deeply mourns the passing of Lic. Cristiam Arancibia, first Director of the Chapter of Technicians and Nurses,...

Watch Again: Pulmonary Embolism in 2025 — Risk Stratification and Novel Therapeutic Approaches

solaci - 0
Our webinar “Pulmonary Embolism in 2025: Risk Stratification and Novel Therapeutic Approaches” is now available to watch. The session took place on November 25,...

Access

Adolfo Alsina 2653 · Piso 2H · CABA · Buenos Aires · Argentina · (5411) 4954 7173 · info@solaci.org · solaci.org · Terms of Use -Privacy Policy